You are here

drug development

J&J bags $150M option on Genmab's Darzalex successor

Fierce Biotech

Tue, 06/11/19 - 09:34 am

Multiple Myeloma

drug development

Biotechs dive deeper into targeted cancer research, despite costs

Biopharma Dive

Thu, 06/6/19 - 09:31 am

clinical trials

drug development

Dana-Farber’s 4-year legal battle shines a light on the origins of PD-1 research — forcing a reckoning on who pioneered the landmark cancer breakthrough

Endpoints

Sun, 05/19/19 - 04:00 pm

drug development

PD-1 inhibitors

Are Phages the Wave of the Future? Using Viruses to Treat Bacterial Diseases

BioSpace

Thu, 05/16/19 - 10:26 am

drug development

Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs

Endpoints

Tue, 05/14/19 - 09:56 am

Alzheimer's disease

drug development

Pfizer selects first GPCR candidate from Sosei Heptares tie-up

Pharmaforum

Tue, 05/14/19 - 09:53 am

drug development

A new study sparks a war of words over the drug industry’s commitment to research

Stat

Tue, 05/14/19 - 09:51 am

drug development

Bicycle Therapeutics Updates Filing for $80 Million IPO

CP Wire

Tue, 05/14/19 - 09:33 am

Bicycle Therapeutics

drug development

Spectrum bags cancer drugs, interferon platform from ImmunGene

Fierce Biotech

Thu, 05/9/19 - 10:46 am

Spectrum Pharmaceuticals

drug development

Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases

Marketwatch

Wed, 05/8/19 - 12:37 pm

Gilead Sciences

drug development

Artificial Intelligence is Ramping up in Drug Development

BioSpace

Tue, 05/7/19 - 06:50 pm

drug development

artificial intelligence

Old Evaluation Systems Are Inadequate For AI Health Care And Drug Development Ecosystem

Forbes

Sun, 05/5/19 - 06:53 pm

artificial intelligence

drug development

After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug

NPR

Sat, 05/4/19 - 02:35 pm

Alzheimer's disease

drug development

AstraZeneca ups oncolytic virus activity with Transgene deal

Fierce Biotech

Thu, 05/2/19 - 11:22 am

oncolytic viruses

drug development

Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge

Stat

Thu, 05/2/19 - 11:13 am

antibiotic resistance

drug development

Caris aims to bridge gap between patients, precision trials with Pharmatech takeout

BioCentury

Thu, 05/2/19 - 10:15 am

molecular profiling

drug development

precision medicine

clinical trials

Reports: Odds of Getting Drugs to Market Range from 6% to 40%

BioSpace

Tue, 04/30/19 - 11:57 am

drug development

Biogen says it will not give up on Alzheimer’s after failed trials

Marketwatch

Sun, 04/28/19 - 12:18 pm

drug development

Alzheimer's disease

Patient access pitfalls, regulatory inconsistencies hamper tissue agnostic drugs

BioCentury

Fri, 04/26/19 - 07:41 pm

drug development

clinical trials

tissue-agnostic drugs

A decade of incentives to promote antibiotic development and still no viable route to commercial success

BioWorld

Thu, 04/25/19 - 11:19 pm

drug development

Pages